<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
 <result pre="underlying diseases, monitoring and management of convalescent plasma therapy, providing" exact="emotional" post="counselling and psychological support, and providing scientific information about"/>
 <result pre="to facilitate the pandemic control. In December 2019, the Coronavirus" exact="Disease" post="2019 (COVID-19) epidemic caused by the novel coronavirus (SARS-CoV-2)"/>
 <result pre="(March 30), 693224 cases have been confirmed with COVID-19 in" exact="total" post="worldwide, causing 33106 deaths. WHO has increased the risk"/>
 <result pre="patients may quickly progress to severe or critical cases, with" exact="acute respiratory distress syndrome" post="(ARDS), sepsis and multiple organ dysfunction, particular in patients"/>
 <result pre="may quickly progress to severe or critical cases, with acute" exact="respiratory" post="distress syndrome (ARDS), sepsis and multiple organ dysfunction, particular"/>
 <result pre="progress to severe or critical cases, with acute respiratory distress" exact="syndrome" post="(ARDS), sepsis and multiple organ dysfunction, particular in patients"/>
 <result pre="organ dysfunction, particular in patients with complicated underlying diseases (diabetes," exact="cardiovascular disease," post="malignancy, etc.).4,5 Therefore, personalized, collaborative and multidisciplinary management is"/>
 <result pre="National Health Committee (NHC) of China, WHO, and Centers for" exact="Disease" post="Control and Prevention (CDC) of the United States.7, 8,"/>
 <result pre="pharmacists should provide strengthened pharmaceutical care services. In addition, the" exact="emotional" post="status of COVID-19 patients is also an important factor"/>
 <result pre="It's necessary for hospital pharmacists to provide COVID-19 patients with" exact="emotional" post="counselling and psychological support. Given the importance and urgency"/>
 <result pre="and were summarized in Table 1 . In addition, the" exact="American" post="Sosiety of Health-System Pharmacist (ASHP) provided an evidence table"/>
 <result pre="combined with other antiviral drugs can shorten the time of" exact="viral" post="nucleic acid turning negative and improve the results of"/>
 <result pre="interferon-α-2b, triple combination of arbidol can shorten the time of" exact="viral" post="nucleic acid turning negative and hospitalization time (P &amp;lt;"/>
 <result pre="retrospective study17 showed no significant difference of the time of" exact="viral" post="nucleic acid turning negative among arbidol treatment, lopinavir-ritonavir treatment"/>
 <result pre="open-label, non-randomized clinical trial18 suggested, compared with the rate of" exact="viral" post="nucleic acid turning negative of control group (12.5%), combination"/>
 <result pre="monotherapy of hydroxychloroquine sulfate (57.1%) significantly improved the rate of" exact="viral" post="nucleic acid turning negative (P &amp;lt; 0.001). The effect"/>
 <result pre="both act as an antiviral therapy against SARS-CoV-2 and prevent" exact="bacterial" post="super-infections. However, a prospective study19 showed that, for patients"/>
 <result pre="COVID-19, the effect on the rate and the time of" exact="viral" post="nucleic acid turning negative were not significant. In addition,"/>
 <result pre="and use antiviral drugs rationally. Immunomodulators According to WHO guidance,8" exact="systemic" post="corticosteroids are not recommended to be routinely used for"/>
 <result pre="are not recommended to be routinely used for treatment of" exact="viral pneumonia" post="outside of clinical trials. CDC guidance9 recommended that corticosteroids"/>
 <result pre="not recommended to be routinely used for treatment of viral" exact="pneumonia" post="outside of clinical trials. CDC guidance9 recommended that corticosteroids"/>
 <result pre="progress in imaging, corticosteroids can be used conditionally in a" exact="short" post="period of time. A retrospective study21 showed that for"/>
 <result pre="and sepsis as soon as possible. Chinese guidance7 recommended that" exact="blind" post="or inappropriate use of antibiotics should be avoided, especially"/>
 <result pre="Chinese guidance,7 tocilizumab is recommended for severe patients with extensive" exact="lung disease" post="and elevated IL-6 levels. For severe patients with rapid"/>
 <result pre="guidance,7 tocilizumab is recommended for severe patients with extensive lung" exact="disease" post="and elevated IL-6 levels. For severe patients with rapid"/>
 <result pre="disease and elevated IL-6 levels. For severe patients with rapid" exact="disease" post="progression and excessive activation of inflammatory response, short-term corticosteroids"/>
 <result pre="stage. Some therapeutic drugs may cause serious adverse reactions, including" exact="hemolytic anemia," post="cardiotoxicity, infection, femoral head necrosis, and teratogenic effects. Therefore,"/>
 <result pre="drug interactions Antiviral medications are related to many drug interactions." exact="Severe" post="COVID-19 patients tend to have underlying diseases, and the"/>
 <result pre="COVID-19 patients tend to have underlying diseases, and the combined" exact="symptomatic" post="drugs are more complicated. Therefore, in order to avoid"/>
 <result pre="full consideration. It is recommended to use medications with FDA" exact="Pregnancy" post="Category B or C, and avoid using medications of"/>
 <result pre="of the SARS-CoV-2 and prevent drugs’ harm to infants through" exact="breast" post="milk, pharmacists should advise lactating patients to suspend breastfeeding.23"/>
 <result pre="be adjusted.24 For elderly patients with impaired immunity or complicated" exact="chronic" post="diseases, pharmacists should adjust the dosage according to their"/>
 <result pre="according to their liver and kidney function, manage medications for" exact="secondary" post="prevention, and pay close attention to drug interactions. Pharmaceutical"/>
 <result pre="combined underlying diseases COVID-19 patients with combined underlying diseases (diabetes," exact="cardiovascular disease," post="chronic obstructive pulmonary disease (COPD), malignancy, bacterial or fungal"/>
 <result pre="diseases COVID-19 patients with combined underlying diseases (diabetes, cardiovascular disease," exact="chronic" post="obstructive pulmonary disease (COPD), malignancy, bacterial or fungal infections"/>
 <result pre="patients with combined underlying diseases (diabetes, cardiovascular disease, chronic obstructive" exact="pulmonary disease" post="(COPD), malignancy, bacterial or fungal infections and organ transplantation,"/>
 <result pre="with combined underlying diseases (diabetes, cardiovascular disease, chronic obstructive pulmonary" exact="disease" post="(COPD), malignancy, bacterial or fungal infections and organ transplantation,"/>
 <result pre="diseases (diabetes, cardiovascular disease, chronic obstructive pulmonary disease (COPD), malignancy," exact="bacterial" post="or fungal infections and organ transplantation, etc.) are prone"/>
 <result pre="disease, chronic obstructive pulmonary disease (COPD), malignancy, bacterial or fungal" exact="infections" post="and organ transplantation, etc.) are prone to disease progress."/>
 <result pre="or fungal infections and organ transplantation, etc.) are prone to" exact="disease" post="progress. Medication regimens for those patients are more complicated"/>
 <result pre="general.25 There are many interactions between antiviral drugs and other" exact="symptomatic" post="drugs, and medication efficacy and safety may be affected."/>
 <result pre="may reduce the anticoagulant effect of warfarin, lopinavir-ritonavir may worsen" exact="diabetes" post="and enhance the anti-hypertensive effect of nifedipine. Monitoring and"/>
 <result pre="of convalescent plasma therapy (CPT) For COVID-19 patients with rapid" exact="disease" post="progression, severe or critical condition, the convalescent plasma therapy"/>
 <result pre="assist clinicians in assessing patients' indications of CPT, combining with" exact="allergy" post="history, contraindications of plasma transfusion, and individual clinical conditions."/>
 <result pre="adverse effects. Common adverse transfusion reactions include transfusion-related circulation overload," exact="acute" post="lung injury, dyspnea, allergic, hypotension, non-hemolytic febrile, acute hemolytic"/>
 <result pre="circulation overload, acute lung injury, dyspnea, allergic, hypotension, non-hemolytic febrile," exact="acute" post="hemolytic transfusion reactions, and delayed hemolytic transfusion reaction, infectious"/>
 <result pre="febrile, acute hemolytic transfusion reactions, and delayed hemolytic transfusion reaction," exact="infectious" post="transfusion reaction, etc. Emotional counselling and psychological support The"/>
 <result pre="daily life after hospitalization, together with the uncertainty about the" exact="disease" post="progress may lead to anxiety, panic, concern and excessive"/>
 <result pre="Pharmacists should pay full attention to the mental health and" exact="emotional" post="management of patients during pharmaceutical care.28 Timely emotional counselling"/>
 <result pre="health and emotional management of patients during pharmaceutical care.28 Timely" exact="emotional" post="counselling and psychological support shall be provided to help"/>
 <result pre="problem, referral to psychiatrists shall be made. For patients with" exact="mental disorders" post="(such as depression and anxiety disorder), pharmacists should pay"/>
 <result pre="shall be made. For patients with mental disorders (such as" exact="depression" post="and anxiety disorder), pharmacists should pay close attention to"/>
 <result pre="made. For patients with mental disorders (such as depression and" exact="anxiety" post="disorder), pharmacists should pay close attention to their psychotropic"/>
 <result pre="diseases, monitoring and management of convalescent plasma therapy (CPT), providing" exact="emotional" post="counselling and psychological support and providing scientific information about"/>
 <result pre="conflicts of interest. References References 1World Health OrganizationRolling updates on" exact="coronavirus disease" post="(COVID-19): WHO characterizes COVID-19 as a pandemichttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen2020 2World Health"/>
 <result pre="of interest. References References 1World Health OrganizationRolling updates on coronavirus" exact="disease" post="(COVID-19): WHO characterizes COVID-19 as a pandemichttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen2020 2World Health"/>
 <result pre="(COVID-19): WHO characterizes COVID-19 as a pandemichttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen2020 2World Health OrganizationCoronavirus" exact="disease" post="2019 (COVID-19) situation report –70https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200330-sitrep-70-covid-19.pdf?sfvrsn=7e0fe3f8_22020 3National Health Commission of"/>
 <result pre="coronavirus pneumoniahttp://www.nhc.gov.cn/tigs/s7848/202001/808bbf75e5ce415aa19f74c78ddc653f.shtml2020 4ZhouF.YuT.DuR.H.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
 <result pre="retrospective cohort studyLancet2020 5ChenT.WuD.ChenH.L.Clinical characteristics of 113 deceased patients with" exact="coronavirus disease" post="2019: retrospective studyThe BMJ2020 6International Pharmaceutical FederationCORONAVIRUS SARS-CoV-2/COVID-19 PANDEMIC:"/>
 <result pre="cohort studyLancet2020 5ChenT.WuD.ChenH.L.Clinical characteristics of 113 deceased patients with coronavirus" exact="disease" post="2019: retrospective studyThe BMJ2020 6International Pharmaceutical FederationCORONAVIRUS SARS-CoV-2/COVID-19 PANDEMIC:"/>
 <result pre="COVID-19 (trial version 7)https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVID-19.V7.pdf2020 8World Health OrganizationClinical management of severe" exact="acute" post="respiratory infection (SARI) when COVID-19 disease is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected2020 9Centers"/>
 <result pre="(trial version 7)https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVID-19.V7.pdf2020 8World Health OrganizationClinical management of severe acute" exact="respiratory" post="infection (SARI) when COVID-19 disease is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected2020 9Centers for"/>
 <result pre="version 7)https://www.chinadaily.com.cn/pdf/2020/1.Clinical.Protocols.for.the.Diagnosis.and.Treatment.of.COVID-19.V7.pdf2020 8World Health OrganizationClinical management of severe acute respiratory" exact="infection" post="(SARI) when COVID-19 disease is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected2020 9Centers for Disease"/>
 <result pre="OrganizationClinical management of severe acute respiratory infection (SARI) when COVID-19" exact="disease" post="is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected2020 9Centers for Disease Control and PreventionU.S. Interim"/>
 <result pre="respiratory infection (SARI) when COVID-19 disease is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected2020 9Centers for" exact="Disease" post="Control and PreventionU.S. Interim clinical guidance for management of"/>
 <result pre="PreventionU.S. Interim clinical guidance for management of patients with confirmed" exact="coronavirus disease" post="(COVID-19)https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html2020 10Lam UngC.O.Community pharmacist in public health emergencies: quick"/>
 <result pre="Interim clinical guidance for management of patients with confirmed coronavirus" exact="disease" post="(COVID-19)https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html2020 10Lam UngC.O.Community pharmacist in public health emergencies: quick"/>
 <result pre="15YuA.R.FanX.ZhaoY.Retrospective Study of the Clinical Efficacy and Safety of Lopinavir/ritonavir" exact="Combined" post="with Other Antiviral in the Treatment of Coronavirus Disease"/>
 <result pre="Lopinavir/ritonavir Combined with Other Antiviral in the Treatment of Coronavirus" exact="Disease" post="(COVID-19)2020Herald of Medicinehttp://kns.cnki.net/kcms/detail/42.1293.R.20200309.1902.002.html 16WeiR.N.ZhengN.H.JiangX.G.Early antiviral therapy of abidor combined"/>
 <result pre="combined with lopinavir/ritonavir and re-combinant interferonα-2b in patients with novel" exact="coronavirus pneumonia" post="in Zhejiang: a multicenter and prospective studyChin J Clin"/>
 <result pre="with lopinavir/ritonavir and re-combinant interferonα-2b in patients with novel coronavirus" exact="pneumonia" post="in Zhejiang: a multicenter and prospective studyChin J Clin"/>
 <result pre="patients with COVID-19https://www.fda.gov/media/136534/download2020 21NiQ.DingC.LiytRetrospective study of low-to-moderate dose glucocorticoids on" exact="viral" post="clearance in patients with novel coronavirus pneumoniaChin J Clin"/>
 <result pre="and gynecology, Chinese medical doctor association. Proposed management of 2019-novel" exact="coronavirus infection" post="during pregnancy and puerperiumChin J Prev Med2320207379 24Chinese Pharmaceutical"/>
 <result pre="gynecology, Chinese medical doctor association. Proposed management of 2019-novel coronavirus" exact="infection" post="during pregnancy and puerperiumChin J Prev Med2320207379 24Chinese Pharmaceutical"/>
</results>
